Artificial Heart Lung Machines Sales

Artificial Heart Lung Machines Sales Market Outlook

The global artificial heart-lung machines market is poised for significant growth, projected to reach USD 1.2 billion by 2035, growing at a CAGR of 8.5% from 2025 to 2035. This growth can be attributed to various factors, including the increasing prevalence of cardiovascular diseases, rising geriatric population, and advancements in medical technology. Additionally, the growing demand for organ transplantation procedures and the rising number of surgeries requiring support from heart-lung machines are also contributing to this market expansion. Increased investments in healthcare infrastructure and innovations through research and development further enhance the potential for market growth. The growing awareness of advanced therapeutic options among patients and healthcare providers will serve to bolster adoption rates, ultimately shaping the future landscape of the artificial heart-lung machines market.

Growth Factor of the Market

A multitude of factors are propelling the growth of the artificial heart-lung machines market. The aging population is particularly susceptible to heart and respiratory diseases, which has resulted in a higher demand for effective surgical interventions. Furthermore, growing incidences of congenital heart defects and chronic respiratory conditions have intensified the need for advanced medical devices. Technological advancements in machine design and user-friendliness have also facilitated greater acceptance and usability of these devices in clinical settings. Additionally, the increasing number of hospitals and surgical centers equipped to perform complex cardiac procedures is driving demand for these machines. Healthcare policies emphasizing improved patient outcomes and the incorporation of innovative technologies are creating a conducive environment for market growth. Lastly, the expansion of healthcare systems in emerging economies is expected to provide significant opportunities for market players.

Key Highlights of the Market

• The artificial heart-lung machines market is projected to grow significantly from USD 1.2 billion by 2035.
• Technological advancements are leading to improved designs and functionalities in heart-lung machines.
• Increasing prevalence of cardiovascular diseases is driving demand for these advanced medical devices.
• Emerging markets are expected to contribute significantly to market expansion.
• Rising awareness regarding organ transplantation procedures is enhancing market potential.

By Product Type

Single Pump Machines:

Single pump machines are specifically designed to handle either oxygenation or circulation, offering a cost-effective solution for many healthcare facilities. These machines are often preferred in less complex surgeries where only partial support is required. The compact design of single pump machines makes them more user-friendly, facilitating easier transportation and setup in emergency situations. Their lower cost compared to double pump systems allows for wider accessibility, especially in smaller hospitals and clinics. Furthermore, advancements in pump technology have led to enhanced performance and reliability in single pump machines, making them a favorable choice for medical practitioners looking to optimize patient care without incurring exorbitant expenses. As a result, the single pump machine segment is expected to witness robust growth during the forecast period.

Double Pump Machines:

Double pump machines are equipped with two pumps, enabling simultaneous circulation and oxygenation of the blood, which is particularly advantageous in complex surgical procedures. These machines are often utilized in open heart surgeries and other high-risk operations. The dual functionality allows for a more controlled environment, ensuring that patients receive adequate blood flow and oxygenation during critical surgical processes. The growing number of institutions performing advanced cardiac surgeries is driving the demand for double pump machines, as they can accommodate a variety of patient needs. Manufacturers are also investing in research to develop more efficient double pump machines that integrate advanced features such as automated monitoring and real-time adjustments. As such, the double pump machine segment is expected to contribute significantly to market revenue in the coming years.

Portable Machines:

Portable artificial heart-lung machines are revolutionizing patient care by allowing for mobility during treatment. These machines are particularly beneficial in emergency situations where patients need swift transportation to specialized care facilities. Their compact and lightweight design without compromising performance is making them increasingly popular among first responders and healthcare providers. Additionally, portable machines prove advantageous in remote areas where conventional medical facilities are not readily accessible. The growing trend towards minimally invasive surgeries requiring portable solutions is further driving this segment's growth. As healthcare providers continuously seek ways to enhance patient care, the demand for portable heart-lung machines is expected to surge, presenting lucrative opportunities for manufacturers.

Neonatal Machines:

Neonatal heart-lung machines are specifically designed to cater to the unique needs of infants requiring respiratory and cardiac support. These machines are smaller, specially calibrated, and equipped with advanced monitoring systems to ensure optimal care for neonates. The increasing incidence of congenital heart defects and prematurity is fueling the demand for neonatal machines, as specialized treatment is often required for this sensitive patient group. Moreover, advancements in medical technology have led to the development of more sophisticated neonatal machines that offer better precision and reliability. As healthcare institutions prioritize neonatal care, this segment is anticipated to witness substantial growth over the forecast period, contributing positively to the overall artificial heart-lung machines market.

Pediatric Machines:

Pediatric heart-lung machines are designed to meet the specific physiological requirements of children undergoing cardiac procedures. These machines provide tailored support for blood flow and oxygenation, ensuring that the unique anatomical and physiological considerations of pediatric patients are met. The increasing prevalence of pediatric cardiac diseases is driving market demand for these specialized devices. As surgical techniques advance and become more complex, the necessity for pediatric heart-lung machines equipped with modern technology has intensified. Manufacturers are focusing on innovation to improve the safety and effectiveness of these machines, thus enhancing their adoption in pediatric cardiology. This segment is forecasted to experience substantial growth, further solidifying its importance in the artificial heart-lung machines market.

By Application

Cardiac Surgery:

The application of artificial heart-lung machines in cardiac surgery is pivotal, primarily due to their role in supporting patients undergoing major cardiac procedures. These machines enable surgeons to operate on a still and bloodless field, ultimately improving surgical outcomes. The increasing incidence of coronary artery disease and other cardiac conditions necessitates the use of heart-lung machines, thereby driving demand in this segment. With continuous advancements in surgical techniques and technologies, the reliance on these machines within the surgical setting is expected to grow. As healthcare providers pursue better patient outcomes, the cardiac surgery application will remain a cornerstone of the artificial heart-lung machines market.

Respiratory Surgery:

Artificial heart-lung machines have significant applications in respiratory surgeries, where they play a crucial role in providing oxygenation and circulation support. These machines assist in surgeries like lung transplants, thoracic surgeries, and procedures on patients with severe respiratory conditions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and other respiratory disorders is increasing the number of surgeries requiring ventilatory support. The evolution of techniques and protocols in respiratory care is further enhancing the utilization of heart-lung machines in this domain. As research continues to yield better modalities for managing respiratory conditions, the demand for these machines in respiratory surgery applications is expected to witness consistent growth.

Extracorporeal Membrane Oxygenation (ECMO):

Extracorporeal membrane oxygenation (ECMO) has emerged as a critical application for artificial heart-lung machines, providing life-saving support for patients with severe pulmonary or cardiac failure. ECMO systems allow for prolonged support, enabling patients to recover from otherwise fatal conditions. The increasing incidence of conditions requiring ECMO, such as pneumonia, cardiomyopathy, and respiratory distress syndrome, is driving demand for these specialized machines. Advances in ECMO technology have improved patient outcomes, resulting in increased acceptance among healthcare providers. As ECMO becomes an integral part of critical care protocols, the application segment for artificial heart-lung machines will likely expand, contributing significantly to overall market growth.

Others:

The "Others" category encompasses various applications of artificial heart-lung machines that do not fall under the primary classifications. This includes niche surgical procedures and experimental applications in research settings. As medical technology continues to evolve, novel applications for heart-lung machines are being explored, thereby creating new opportunities for market players. The flexibility of these machines allows them to be utilized in a variety of clinical scenarios beyond traditional surgical applications. This broadens the scope for growth and innovation within the market, as manufacturers seek to adapt their products to meet the changing needs of healthcare providers. The "Others" segment is expected to gain traction as healthcare systems embrace advanced technologies for diverse applications.

By Extracorporeal Membrane Oxygenation

Veno-Arterial (VA) ECMO:

Veno-arterial (VA) ECMO is a critical application of artificial heart-lung machines that provides both cardiac and respiratory support to patients in severe cardiac failure. This technique involves the extraction of deoxygenated blood from the venous system, oxygenation through the machine, and subsequent return to the arterial system, bypassing the heart altogether. VA ECMO is often utilized in cases of cardiogenic shock, cardiac arrest, or during complicated cardiac surgeries. The growing incidence of these conditions is driving the demand for VA ECMO, as healthcare providers seek to improve patient outcomes through advanced support systems. Continuous innovation in VA ECMO technology, including miniaturization and enhanced monitoring, is expected to further elevate its importance in the artificial heart-lung machines market.

Veno-Venous (VV) ECMO:

Veno-venous (VV) ECMO is primarily used for patients who require respiratory support due to severe pulmonary failure, allowing for oxygenation of blood without providing circulatory support. This technique is essential in cases of acute respiratory distress syndrome (ARDS) or severe pneumonia, where traditional ventilation methods are inadequate. The increasing prevalence of respiratory illnesses is fueling demand for VV ECMO systems, as they offer a means to manage severe hypoxemia effectively. As healthcare providers continue to adopt VV ECMO as a standard treatment modality, advancements in technology and techniques are likely to enhance its efficacy, solidifying its role in the artificial heart-lung machines market.

By Distribution Channel

Hospitals:

Hospitals represent the primary distribution channel for artificial heart-lung machines, serving as the main settings for their application. The demand in this sector is driven by the increasing number of complex surgical procedures, particularly in cardiology and pulmonary medicine. Hospitals equipped with advanced surgical facilities require reliable heart-lung machines to support their surgical teams during procedures. As healthcare systems expand and upgrade their surgical capabilities, the need for high-quality heart-lung machines is anticipated to grow correspondingly. Furthermore, the rising number of hospitals specializing in cardiac and respiratory care is expected to provide a significant boost to the segment, contributing to overall market growth.

Specialty Clinics:

Specialty clinics are increasingly becoming important distribution channels for artificial heart-lung machines, particularly those focusing on cardiology and respiratory care. These clinics often provide targeted services and advanced procedures, requiring specialized machines to enhance patient outcomes. The rise of outpatient surgical procedures has led to a greater demand for these devices in specialized settings. Additionally, as patients seek advanced treatments in non-hospital environments, specialty clinics are adapting by incorporating heart-lung machines into their offerings. The growth of this segment reflects a broader trend towards more specialized and patient-focused care, which is expected to continue driving demand for artificial heart-lung machines.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as significant distribution channels for artificial heart-lung machines, particularly for less invasive procedures that require short-term support. The convenience and efficiency of ASCs make them an attractive option for patients, resulting in an increase in elective surgeries that may involve the use of heart-lung machines. As ASCs implement more advanced technologies to cater to a growing patient population, the demand for these machines will likely escalate. The rise of outpatient surgeries and the focus on cost-effective healthcare solutions are expected to further solidify the role of ASCs in the artificial heart-lung machines market.

Online Sales:

The online sales channel for artificial heart-lung machines is an emerging segment that is gaining momentum due to the increasing digitalization of healthcare. This channel allows manufacturers and distributors to reach a broader audience and facilitates easier access to medical devices for healthcare providers. The growing trend of e-commerce in the healthcare sector is driving this shift, as institutions look for convenient and efficient ways to procure medical equipment. Online platforms also offer comprehensive product information and competitive pricing, appealing to various healthcare providers. As digital solutions become more integrated into the purchasing processes, online sales of artificial heart-lung machines are expected to witness considerable growth in the coming years.

By Region

The North American region is anticipated to dominate the artificial heart-lung machines market, accounting for approximately 40% of the total market share by 2035. The high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and significant investments in medical technology contribute to this regional growth. The presence of key manufacturers and ongoing research initiatives further support North America's leadership in this market. The region is also characterized by a high level of awareness about advanced healthcare solutions, driving demand for artificial heart-lung machines in hospitals and surgical centers. Furthermore, a favorable regulatory environment and a substantial geriatric population will continue to bolster growth in North America, with a CAGR of around 9% expected during the forecast period.

In Europe, the market is projected to witness steady growth, capturing approximately 30% of the market share by 2035. The region is seeing a growing emphasis on patient-centric care and the adoption of innovative medical technologies. Countries such as Germany, France, and the UK are at the forefront, investing in advanced surgical technologies and healthcare infrastructure. The increasing geriatric population and escalating prevalence of respiratory and cardiac diseases are further fueling demand for artificial heart-lung machines. With a projected CAGR of around 7% during the forecast period, Europe is likely to maintain its position as a significant player in this market, contributing to the overall global landscape.

Opportunities

The growing focus on research and development in the healthcare sector presents significant opportunities for manufacturers of artificial heart-lung machines. With the advent of new materials and technologies, the potential for creating more compact, efficient, and user-friendly devices is immense. Innovations in telemedicine and remote monitoring are also paving the way for advanced integrations with heart-lung machines, enabling healthcare providers to monitor patients in real-time and make timely interventions when necessary. Furthermore, as healthcare providers increasingly prioritize patient outcomes, the integration of artificial intelligence and machine learning algorithms into these machines can enhance their functionality, making them more responsive to patient needs. This creates a fertile ground for new product developments and captures a larger market share. Companies that focus on providing cutting-edge solutions and addressing emerging healthcare challenges will likely find themselves at the forefront of this evolving market.

Additionally, the rising demand for organ transplantation offers a unique opportunity for growth in the artificial heart-lung machines market. As organ donation rates increase and more patients seek transplantation for severe heart and lung conditions, the need for machines that can facilitate these procedures is paramount. The development of machines that can support organ preservation and transportation further enhances market prospects. Collaborations between manufacturers and healthcare institutions to develop specialized heart-lung machines for transplantation procedures will likely yield significant benefits. Moreover, expanding access to healthcare in emerging markets presents an opportunity for growth, as these regions invest in modern medical technologies to improve patient care. As demand surges in these areas, addressing the specific needs of diverse populations will be vital for companies aiming to capture new market segments.

Threats

While the artificial heart-lung machines market is poised for growth, several threats could hinder its expansion. One of the primary challenges is the regulatory landscape, as manufacturers must navigate strict guidelines regarding the approval and use of medical devices. Changes in regulations or delays in the approval process can significantly impact product launches and market entry, constraining revenue potential. Additionally, the high costs associated with the development and production of advanced heart-lung machines may deter smaller manufacturers from entering the market, leading to reduced competition and innovation. Furthermore, the market is susceptible to economic fluctuations that could affect healthcare budgets and spending on advanced medical technologies. Such economic uncertainties can lead to decreased investments in healthcare infrastructure and advanced devices, posing challenges for growth in the sector.

Moreover, manufacturers face increasing competition from alternative therapies and treatment options, which could diminish the demand for artificial heart-lung machines. As advancements in minimally invasive surgical techniques and pharmacological therapies continue to evolve, healthcare providers may opt for these alternatives over traditional surgical interventions requiring heart-lung machines. Additionally, the rapid pace of technological advancements means that manufacturers must constantly innovate to stay relevant. Failure to keep up with evolving technologies or changes in market demands may result in a loss of market share. To overcome these threats, manufacturers must proactively adapt to regulatory changes, invest in research and development, and remain responsive to competitive pressures in the healthcare landscape.

Competitor Outlook

• Cleveland Medical Devices
• AstraZeneca PLC
• Cameron Health, Inc.
• Terumo Cardiovascular Systems Corporation
• Getinge AB
• Cardinal Health, Inc.
• Fresenius Kabi AG
• Maquet Holding B.V.
• Janssen Pharmaceuticals
• Abbott Laboratories
• GE Healthcare
• Boston Scientific Corporation
• Philips Healthcare
• Siemens Healthineers

The overall competitive landscape of the artificial heart-lung machines market is characterized by a mix of established players and emerging companies striving to capture market share through innovation and technological advancements. Key players in the market are focusing on enhancing their product offerings and expanding their geographical reach through strategic partnerships and collaborations. Mergers and acquisitions have also become common as companies seek to bolster their capabilities and strengthen their market positions. Additionally, manufacturers are emphasizing research and development to introduce next-generation heart-lung machines that incorporate advanced features such as digital connectivity, real-time monitoring, and improved user interfaces. The increasing emphasis on patient safety and regulatory compliance is prompting companies to invest heavily in quality assurance and risk management practices.

Cleveland Medical Devices is a notable player in the artificial heart-lung machines market, with an established reputation for producing high-quality and reliable devices. The company's commitment to innovation and advanced engineering has positioned it as a leader in the industry. AstraZeneca PLC, a global player with a diverse portfolio, is also making strides in this market by developing integrated solutions that combine devices with pharmaceuticals for improved patient outcomes. Medtronic plc remains a key competitor, leveraging its extensive expertise in cardiac care to enhance its product offerings and expand its market presence. Terumo Cardiovascular Systems Corporation is known for its focus on developing minimally invasive technologies, making it a strong contender in the artificial heart-lung machines market.

Getinge AB and Cardinal Health, Inc. are also significant players, offering a wide range of medical devices, including artificial heart-lung machines. Getinge's commitment to innovation and sustainability has solidified its position in the market, while Cardinal Health's extensive distribution network facilitates the availability of devices to healthcare providers. Furthermore, Fresenius Kabi AG continues to expand its product portfolio by integrating advanced technologies into its heart-lung machines, catering to the growing demand for sophisticated patient care solutions. The competitive landscape is continuously evolving, with companies increasingly focusing on addressing the specific needs of healthcare providers and adapting their strategies to align with changing market dynamics.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Getinge AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GE Healthcare
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 AstraZeneca PLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Fresenius Kabi AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Philips Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Maquet Holding B.V.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cameron Health, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Janssen Pharmaceuticals
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cleveland Medical Devices
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Terumo Cardiovascular Systems Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Artificial Heart Lung Machines Sales Market, By Application
    • 6.1.1 Cardiac Surgery
    • 6.1.2 Respiratory Surgery
    • 6.1.3 Extracorporeal Membrane Oxygenation (ECMO)
    • 6.1.4 Others
  • 6.2 Artificial Heart Lung Machines Sales Market, By Product Type
    • 6.2.1 Single Pump Machines
    • 6.2.2 Double Pump Machines
    • 6.2.3 Portable Machines
    • 6.2.4 Neonatal Machines
    • 6.2.5 Pediatric Machines
  • 6.3 Artificial Heart Lung Machines Sales Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Specialty Clinics
    • 6.3.3 Ambulatory Surgical Centers
    • 6.3.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Artificial Heart Lung Machines Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Artificial Heart Lung Machines Sales market is categorized based on

By Product Type

• Single Pump Machines
• Double Pump Machines
• Portable Machines
• Neonatal Machines
• Pediatric Machines

By Application

• Cardiac Surgery
• Respiratory Surgery
• Extracorporeal Membrane Oxygenation (ECMO)
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Sales

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Cleveland Medical Devices
• AstraZeneca PLC
• Cameron Health, Inc.
• Terumo Cardiovascular Systems Corporation
• Getinge AB
• Cardinal Health, Inc.
• Fresenius Kabi AG
• Maquet Holding B.V.
• Janssen Pharmaceuticals
• Abbott Laboratories
• GE Healthcare
• Boston Scientific Corporation
• Philips Healthcare
• Siemens Healthineers